Our own interrogation of the TCGA-SKCM database suggests that high expression of CD36 correlates with poor clinical outcome for patients with melanoma (albeit not significantly) and corroborates the study by Nath and Chan [45]; thus lending further weight to investigating CD36 in melanoma. Here, CD36 is linked to melanoma.